Zotiraciclib citrateProduct ingredient for Zotiraciclib

Name
Zotiraciclib citrate
Drug Entry
Zotiraciclib

Zotiraciclib is under investigation in clinical trial NCT02942264 (Zotiraciclib (TG02) Plus Dose-dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma).

Accession Number
DBSALT003170
Structure
Synonyms
TG02 Citrate / Zotiraciclib citrate
External IDs
TG-02 citrate / TG02 citrate